TY - JOUR
T1 - Differential response of platelets to chemokines
T2 - RANTES non-competitively inhibits stimulatory effect of SDF-1α
AU - Shenkman, Boris
AU - Brill, A.
AU - Brill, G.
AU - Lider, O.
AU - Savion, N.
AU - Varon, D.
PY - 2004/1
Y1 - 2004/1
N2 - Background: Among the chemokines related to CXC and CC receptor groups and released from platelets, leukocytes and endothelial cells, SDF-1, TARC and MDC have been found to be platelet agonists. Platelets do not contain SDF-1α. In contrast, RANTES is constitutively present in platelet α-granules and released upon platelet activation. Objectives: To study a possible role of RANTES as a modulator of SDF-1α effect on platelets, in relation to CXCR4 and various CC receptors. Methods: CXCR-4 (CXCL12) receptor expression and platelet activation were evaluated by flow cytometry, platelet deposition was studied by cone and plate(let) analyzer, and platelet aggregation by turbidometric aggregometry. Results: Flow cytometry studies revealed similar expression of CXCR-4, the specific receptor of SDF-1α on intact, inactivated, and activated platelets. Preincubation of platelets with RANTES affected neither CXCR-4 expression, nor SDF-1α binding to the platelet membrane. In the presence of fibrinogen, SDF-1α activated gel-filtered platelets. RANTES did not activate platelets, but substantially (by 70%) inhibited SDF-1α-induced fibrinogen binding. Similarly, RANTES abrogated the promoting effect of SDF-1α on whole blood platelet adhesion to endothelial cell monolayer under venous flow conditions. In platelet-rich plasma, RANTES moderately inhibited SDF-1α-induced platelet aggregation, while it did not affect aggregation induced by thrombin-receptor activation peptide, adenosine diphosphate, or phorbol 12-myristate 13-acetate. A synergistic inhibitory effect of RANTES and prostaglandin E1 used at subthreshold concentrations, on SDF-1α-induced aggregation and SDF-1α-induced fibrinogen binding to platelets was observed, which may suggest involvement of RANTES in a cAMP-dependent signal transduction pathway. Conclusions: RANTES non-competitively inhibits activation of platelets by SDF-1α, and thus may play a regulatory role in platelet response to inflammation.
AB - Background: Among the chemokines related to CXC and CC receptor groups and released from platelets, leukocytes and endothelial cells, SDF-1, TARC and MDC have been found to be platelet agonists. Platelets do not contain SDF-1α. In contrast, RANTES is constitutively present in platelet α-granules and released upon platelet activation. Objectives: To study a possible role of RANTES as a modulator of SDF-1α effect on platelets, in relation to CXCR4 and various CC receptors. Methods: CXCR-4 (CXCL12) receptor expression and platelet activation were evaluated by flow cytometry, platelet deposition was studied by cone and plate(let) analyzer, and platelet aggregation by turbidometric aggregometry. Results: Flow cytometry studies revealed similar expression of CXCR-4, the specific receptor of SDF-1α on intact, inactivated, and activated platelets. Preincubation of platelets with RANTES affected neither CXCR-4 expression, nor SDF-1α binding to the platelet membrane. In the presence of fibrinogen, SDF-1α activated gel-filtered platelets. RANTES did not activate platelets, but substantially (by 70%) inhibited SDF-1α-induced fibrinogen binding. Similarly, RANTES abrogated the promoting effect of SDF-1α on whole blood platelet adhesion to endothelial cell monolayer under venous flow conditions. In platelet-rich plasma, RANTES moderately inhibited SDF-1α-induced platelet aggregation, while it did not affect aggregation induced by thrombin-receptor activation peptide, adenosine diphosphate, or phorbol 12-myristate 13-acetate. A synergistic inhibitory effect of RANTES and prostaglandin E1 used at subthreshold concentrations, on SDF-1α-induced aggregation and SDF-1α-induced fibrinogen binding to platelets was observed, which may suggest involvement of RANTES in a cAMP-dependent signal transduction pathway. Conclusions: RANTES non-competitively inhibits activation of platelets by SDF-1α, and thus may play a regulatory role in platelet response to inflammation.
KW - Platelets
KW - RANTES
KW - SDF-1α
UR - http://www.scopus.com/inward/record.url?scp=4444265635&partnerID=8YFLogxK
U2 - 10.1111/j.1538-7836.2004.00527.x
DO - 10.1111/j.1538-7836.2004.00527.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:4444265635
VL - 2
SP - 154
EP - 160
JO - Journal of Thrombosis and Haemostasis
JF - Journal of Thrombosis and Haemostasis
SN - 1538-7933
IS - 1
ER -